Susquehanna Fundamental Investments’s Ocugen OCGN Stock Holding History

Susquehanna Fundamental Investments’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-138,796	Closed	-$247K	–	1398
2022 Q3	$247K	Buy	+138,796	New	+$346K	﹤0.01%	1209
2022 Q1	$458K	Buy	+138,796	New	+$488K	0.01%	1111
2021 Q3	–	Sell	-57,397	Closed	-$461K	–	1829
2021 Q2	$461K	Buy	+57,397	New	+$484K	0.01%	1201

Other funds holding OCGN

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna Fundamental Investments's OCGN Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of Ocugen (OCGN) in Q4 2022, closing a stake of 138,796 shares — an estimated $247K sold.

Susquehanna Fundamental Investments first reported a position in OCGN in Q2 2021 and held it in 3 quarters. The position peaked at $461K in Q2 2021. 114 funds tracked by Wall St. Rank hold OCGN as of Q4 2022.

Susquehanna Fundamental Investments reported no remaining Ocugen position as of Q4 2022 after selling out during the quarter.
Susquehanna Fundamental Investments sold 138,796 Ocugen shares in Q4 2022, an estimated $247K.
Susquehanna Fundamental Investments first reported a position in Ocugen in Q2 2021 and held it in 3 quarters.
Susquehanna Fundamental Investments's Ocugen position peaked at $461K in Q2 2021.
114 funds tracked by Wall St. Rank held Ocugen as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.